Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.
Dimopoulos M; Spencer A; Attal M; Prince HM; Harousseau JL; Dmoszynska A; San Miguel J; Hellmann A; Facon T; Foà R; Corso A; Masliak Z; Olesnyckyj M; Yu Z; Patin J; Zeldis JB; Knight RD; The New England Journal Of Medicine, 2007, vol. 357, issue 21, p 2123, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation